#Cure

Researchers Seek to Repeat the Berlin Patient’s HIV Cure

#Prevention

#PrEP

Researchers Seek to Repeat the Berlin Patient’s HIV Cure

#Prevention

#PrEP

Cure: Cure Collective

Scientists have created a consortium to help them better understand and potentially achieve a cure based on stem cell transplants.

Luis Montaner (right) and a lab assistant at the Wistar Institute retrieve samples from liquid nitrogen frozen storage.

NIH Awards Nearly $150M to Collaborative HIV Cure Research

Plus, the BEAT-HIV Delaney project spells out its “three research pillars.”

Defective HIV DNA May Still Prompt HIV-Related Proteins

Even when HIV is fully suppressed, such viral activity may spur persistent immune activation and complicate cure attempts.

The Big News From the 2016 International AIDS Conference

A roundup of the major presentations on HIV science at the international conference held July 22 to 28 outlines many exciting developments.

Very Early Treatment Keeps Some Women HIV Negative

Starting HIV meds within 15 days of infection prevented the development of antibodies.

Experimental Therapy Fails to Stop Viral Rebound Post–HIV Treatment Interruption

Treatment with vorinostat, hydroxychloroquine and maraviroc had no effect on viral rebound after an HIV treatment interruption.

HIV Antibody 3BNC117 Delays Viral Rebound, Could Be Component of Cure

The injectable antibody 3BNC117 suppressed HIV and delayed viral rebound for up to 19 weeks in people with the virus who stopped their meds.

The HIV Treatment Pipeline

“We need drugs that are gentler, kinder, better and cheaper.”

Charlie Sheen on Charlatans, HIV Pill Fatigue and “the Future of Treatment”

Plus: Lots of women aren’t happy with Sheen as a spokesperson for LELO’s Hex condoms.

$35.6M Grant to Emory University for HIV Cure and Vaccine Research

The NIH funding will help scientists explore how to “shock and kill” latent HIV reservoirs.

35 Things You Might Not Know About HIV

A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.

Researchers Use CRISPR to Edit HIV DNA From Live Animal Cells

Scientists have used the cutting-edge CRISPR/Cas9 gene-editing method to excise a key fragment of HIV’s genetic code from live rodents.

Many People With HIV Are Eager to Participate in Cure Research

Even when facing potential risks, many people with HIV are quite interested in participating in research of potential cures for the virus.

Cure: Cloned Immune Cells

Yet another study has shown the extreme complexity of the viral reservoir, where HIV hides from ARV treatment, frustrating cure attempts.

Clinton Meets With 20 AIDS Activists; Sanders Reschedules

“HIV wonk” Hillary says: “We do have the tools to end this epidemic once and for all.”

Maybe CRISPR Gene Editing Won’t Be Such an Easy Way to Attack HIV After All

HIV can become resistant to CRISPR/Cas9 gene editing just as with antiretroviral (ARV) treatment.

#Cure

Researchers Seek to Repeat the Berlin Patient’s HIV Cure

#Prevention

#PrEP

Researchers Seek to Repeat the Berlin Patient’s HIV Cure

#Prevention

#PrEP

Cure: Cure Collective

NIH Awards Nearly $150M to Collaborative HIV Cure Research

Defective HIV DNA May Still Prompt HIV-Related Proteins

The Big News From the 2016 International AIDS Conference

Very Early Treatment Keeps Some Women HIV Negative

Experimental Therapy Fails to Stop Viral Rebound Post–HIV Treatment Interruption

HIV Antibody 3BNC117 Delays Viral Rebound, Could Be Component of Cure

The HIV Treatment Pipeline

Charlie Sheen on Charlatans, HIV Pill Fatigue and “the Future of Treatment”

$35.6M Grant to Emory University for HIV Cure and Vaccine Research

35 Things You Might Not Know About HIV

Researchers Use CRISPR to Edit HIV DNA From Live Animal Cells

Many People With HIV Are Eager to Participate in Cure Research

Cure: Cloned Immune Cells

Clinton Meets With 20 AIDS Activists; Sanders Reschedules

Maybe CRISPR Gene Editing Won’t Be Such an Easy Way to Attack HIV After All

Newsfeed

Treatment News

Exclusives

Opinions